I believe the question is what product is going to be trialed on Jan 10th. Which is your answer?

Did you notice there was no announced pilot trial first and straight into BE pivotal trial....hmmmm...Could it be once daily Oxycontin? Embeda? The new Oxy product we just learned about...hmmm

Elite told you awhile ago they were qualifying a second supplier......That is not something they would PR when that was official but it would seem to me.....Cha Ching...

So place your bets for the product to be trialed on Jan 10th

A) Once a day oxycontin?

B) Embeda Generic?

C) New Oxy product but unnamed thus far?

I hear a patent just got approved...

That is all one bead IP is worth...41m? Wow what a waste of money by Pfizer....

Good thing Elite's two bead is much more modular. Worth 10x that...

lol $41m...hahaha


That is just Embeda sales from 2011. Been as high as ~$67m


And that was off the top of my head.....Damn...lol...Poor Pfizer

Hey Dr L

One bead IP is worth 3 billions dollars?

Two bead IP is worth ?

Awesome...lol

I am waiting for a credible independent expert to explain why one bead is better, yet it never comes. Hmmmmmmmmmmmmm

No I didn't.

After reading the arguments on both sides it is clear to me that they can be put in two buckets

Buyers
Buyers and holders

That is the two sentiments that I see

Dr L

What do you think this product is entering trials on January 10th happens to be? You think it is the third Oxy product?

Say what was that value on one bead IP?

How many times more valuable would the two bead be?

So what is one bead IP worth? 500 million? 750 million? A billion?

Two bead is much more modular, simply a better idea. So what is that number? lol

Anyone have a patent update?

Really? Tell me again, how many drugs are entering trial and when is this first trial supposed to close? Is that next week?

And what do you think the product is entering studies on Jan 10th might be....hmmm

Hey Dr L

How many ADT products are active in Elite's plan right now? How many entering trials? What are they?

Ahhh melt extrusion....

First Trials end in 8 days on $2.7B Oxy products
Patent to be awarded shortly in an official manner
Numerous approvals pending
Find out the next ART product and trials start in about 4 weeks

So you agree that King bought Alpharma and were very excited about Alpharma then and what you posted earlier was incorrect? Is that what you are saying? You are posting opposing view points at the same time.

You were asked that question. Why isn't it on the govt trials website. Does it need to be posted there. It completes next week doesn't it?

And the next one on an unnamed product starts Jan 10th.

Say how much is one bead worth. More than 500 million dollars? A billion? Put a dollar value on it.

So two bead which is worth much more since it modular is worth what 2x, 3x?

So what is a one bead technology worth is the question that hasn't been answered. It was your claims about how great ALO02 is that started this discussion but folks are looking for an answer as to it's worth. Are you now saying that it is not worth much now, that it is not very good?

We all realize that the two bead system is better and obviously more modular and much more valuable then a one bead system.

Are you saying those dozens of articles saying how excited King was to acquire rights to Embeda were all falsified back in 2008?

Obviously it is very exciting for Elite investors.

Google Embeda - King - Alphma and you can read articles like this one for days

http://www.tricities.com/news/article_d1df2d71-88f4-5fc7-9728-d5c53d10180c.html?mode=jqm

King Closes Alpharma Deal


Mac Mclean | Updated 11 months ago

It might have taken a little longer than they hoped, but King Pharmaceuticals executives announced Tuesday that they had completed their purchase of New Jersey pharmaceutical company Alpharma Inc.


“As a result of this acquisition we are now a stronger, more competitive company,” King President and CEO Brian Markison said in a written news statement announcing the deal.

King first revealed its plans to buy Alpharma in August when it announced that the targeted company’s board rejected a purchase offer of $1.4 billion, or $33 a share.

King’s executives made their first written offer Aug. 4, according to company shareholder records, and then raised the offered price to $37 a share or $1.6 billion on Sept. 11.

Alpharma’s board was quick to reject King’s advances every step of the way and in a few news statements alluded to a possible unnamed third company that could be involved in the deal and was also interested in their company. But Alpharma accepted King’s offer Nov. 24 and the deal was provisionally approved Friday by the Federal Trade Commission, provided that the company sell any assets connected to Kadian, one of Alpharma’s painkillers.

In Tuesday’s statement, King executives announced that their company sold the Kadian assets to Actavis Elizabeth, L.L.C., which also operates out of New Jersey. Actavis will pay King about $127.5 million for the drug depending on how it sells over the next 18 months.

But it is another Alpharma drug, Embeda, that has many King executives excited. King spokesman James Green said Embeda is a morphine drug that is specifically designed to prevent abuse. The drug contains a special core that negates the morphine’s effects when it is crushed, he said.

Green said Embeda would fit nicely with King’s Acurox and Remoxy, two other abuse-resistant painkillers the company been developing.

The U.S. Food and Drug Administration asked King for more information about Remoxy earlier this month, Green said, adding that this step, though routine, delayed King from producing the drug and selling it to its customers.

Which relates back my question which continues to go unanswered...Which is what is a one bead system worth?

King sold for $3.2 Billion dollars

What would a two bead system be worth that is much more modular entering studies on multiple products now...

OMG!!!!!!He oversaw 3000 employees, 25 facilities. Who do you think he was overseeing? Are you saying he wasn't involved in M&A? That is incredibly hilarious. It would be a very small circle of people and he would be one of them.....but we already know that....

Dr LOL can you tell me how many Abuse deterrent Products are being trialed and scheduled for trials in the next couple months?

How many products is Elite having discussions with major pharmas over for partnership?

Hey Dr L

How many Abuse deterrent drugs has the company noted as in development? How many entering studies over the next few months?

Dr L -

Why is a one bead system better when a two bead system is obviously much more modular and stable?

What do you think having IP for a one bead system is worth?

What is IP for a two bead system worth when it is much more modular?

How many products does Elite have in development right now? Scheduled for trials? What is the market for them?

So you agree that at Actavis he was responsible for 3000 employees and 25 facilities globally right?

There is no M&A Global VP. If anything they would report to him...That would be handled under the entire group including Mr Hakim. Thanks for the LOL though

The truth shall set you free. Thanks Couch....

Hey Dr,

True or false. Nasrat oversaw over 3000 employees and 25 facilities worldwide. Had a budget over 300 million dollars.....some QC guy...That is truly lol

Yet he bought 11m shares and took over at Elite....hmmmm

And loaned the company 1m dollar unsecured
And is paid in stock
And was the Global VP at Alppharma overseeing Compliance...which in case anyone didn't know is incredibly important...just helping out with DD...

Dr L -

Why is a one bead system better when a two bead system is obviously much more modular and stable?

What do you think having IP for a one bead system is worth?

What is IP for a two bead system worth when it is much more modular?

How many products does Elite have in development right now? Scheduled for trials? What is the market for them?

You have to specify which products. Elite is in discussions with a major Pharma that is interested. That is correct right?

Elite is also having discussions with another pharma on another product too is that correct?

Ipoint TV is definitely real. I have been critical of this company and find it certainly has shady qualities. I also find it completely fascinating but I would never deny that IPTV is real. It most certainly is.

A lot of folks probably sold when they thought the IPTV deal was dead. I certainly considered selling my holdings but IPTV is the whole point of all this. The TDEY 3D stuff, all the other items.

The application with apple, android is real. The concept is real and the programming for smartphone or smart tv is certainly real.

To be honest it looks like this was a deliberate share grab but letting the filing scare people, sell, get shares and then announce, "nah no issues" but thanks for the shares.

Lots of shady but IPTV is real

I believe this is the link to the android app

https://play.google.com/store/apps/details?id=ru.iptvremote.android.iptv&hl=en

You can download it and try it out. Seems folks like it.

From the CFO as noted below

LOL. That's on one product worth $2.7 billion dollars. I guess Actavis must have been foolish too huh? I am betting the third largest generic drug company in the world knows what they are doing. The best part is Elite has numerous products using this tech now.

Really what you just proved is Elite is undervalued by about 10x. Thanks for that. I am guessing all these companies know what they are doing. And so does Nasrat with his 11m shares and so does Jerry who just bought 6m shares....

Message for the board. - It has become apparent that there are institutions possibly involved using outside sources and resources to manipulate the share price and manipulate investors while it is being accumulated.

You think Elite filed a poison pill, anti hostile takeover filing with the SEC and put in place these measures for the fun of it?

Thank you for proving how valuable Elite's tech is. You realize that is all that you are actually doing.

After reading your thousands of posts it has become apparent just how undervalued Elite must be.

So lets see if I can summarize

Targin may or may not be abuse deterrent although the company previous stated it wasn't and now is trying to get ADT labeling. Scientifically speaking it is not that much of a deterrent and may not be a deterrent at all as the mechanisms can be defeated. However, this only further lends support to showing how valuable Elite is and how well positioned. So unless you are saying how valuable Elite's tech is, Targin is basically irrelevant.

I have not seen an answer on how valuable a one beads tech is and considering how much more valuable a two bead tech that is much more modular and less likely to exhibit stability issues would be.

Elite is still about to get a key patent now.

Elite is under trials now and for the next two weeks, results pending. And a second product is entering full BE studies in a month.

and all the other stuff going on I mentioned previously.....

Dr L -

Why is a one bead system better when a two bead system is obviously much more modular and stable?

What do you think having IP for a one bead system is worth?

What is IP for a two bead system worth when it is much more modular?

How many products does Elite have in development right now? Scheduled for trials? What is the market for them?

I know. We had these discussions over a year ago...

Funny, how I cannot get an answer on what the one bead IP is worth and now it is Targin is the drug of the future.

And what would a two bead system IP be worth since it is much more modular?

If you crush Targin you will get sick and then get high. Naloxone is fast and short acting....But Pharma experts would already know that...And again all it does is validates Elite approach again...

Coming soon to ELTP

Another patent which continues to expand Elite's IP - Reasons for allowance noted on Friday.

Results of the drug trials ending in two weeks

Next drug trial in one month for currently unnamed product. This is a full blast BE study not a pilot. You all realize what is going on here... right?

Multiple drugs pending approval now

Drugs pending transfer and Launch now - Likely will simply announce each Launch - First drug is Isradipine and has only one competitor

Partnership in the works likely based on a balance of equity to Elite versus Big Pharma desire to maximize equity over time = The CEO told you this already. They could have a deal now. Heck the CEO kind of told Couch the same thing basically before he noted it the second time on the CC

By the way there are multiple partnerships in the works.

Dr L -

Why is a one bead system better when a two bead system is obviously much more modular and stable?

What do you think having IP for a one bead system is worth?

What is IP for a two bead system worth when it is much more modular?

How many products does Elite have in development right now? Scheduled for trials? What is the market for them?

I am going to guess that an industry expert like Camargo who is made up of ex FDA higher ups with direct ties to the FDA knows what they are doing here. So I am going to believe them. They are the 505B2 experts. But we already know that.....

Say here is one of the key Questions

Dr L, What is the outcome of the Purdue Pfizer Embeda court case? This is more important then people realize perhaps.

Coming soon to ELTP

Another patent which continues to expand Elite's IP - Reasons for allowance noted on Friday.

Results of the drug trials ending in two weeks

Next drug trial in one month for currently unnamed product. This is a full blast BE study not a pilot. You all realize what is going on here... right?

Multiple drugs pending approval now

Drugs pending transfer and Launch now - Likely will simply announce each Launch - First drug is Isradipine and has only one competitor

Partnership in the works likely based on a balance of equity to Elite versus Big Pharma desire to maximize equity over time = The CEO told you this already. They could have a deal now. Heck the CEO kind of told Couch the same thing basically before he noted it the second time on the CC

By the way there are multiple partnerships in the works.

That was off the top of my head late at night....